HE4 Antibodies

Santa Cruz Biotechnology delivers a wide array of HE4 monoclonal antibodies for research in cancer diagnostics and biomarker discovery. HE4 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HE4, or Human Epididymis Protein 4, is a glycoprotein that plays a significant role in the reproductive system and is increasingly recognized for its importance in ovarian cancer diagnosis and monitoring. Elevated levels of HE4 in serum have been associated with the presence of ovarian tumors, making HE4 a valuable biomarker for early detection and prognosis. Understanding the function and regulation of HE4 can provide insights into tumor biology and aid in the development of targeted therapies. Researchers can utilize HE4 monoclonal antibodies to investigate cellular pathways and molecular mechanisms involved in cancer progression. Advanced research with HE4 monoclonal antibodies has revealed important correlations between HE4 expression patterns and clinical outcomes. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance our understanding of cancer biology and contribute to the development of improved diagnostic tools and treatments.